kentucky semaglutide digestive blockage law office gastric intestinal obstruction attorney semaglutide diarrhea firm in louisiana kentucky semaglutide gastrointestinal obstruction lawyer Wegovy® Lawsuit Ozempic Lawsuit for Blindness, Stomach kentucky semaglutide stomach paralysis law

Weight loss is not a guaranteed outcome and timelines differ significantly from person to person

The safety profile of GLP-1RA drugs generally indicates a low incidence of side effects, although it depends on the dose and the administration mode

Retinopathy: Rapid changes in blood sugar can temporarily worsen diabetic eye disease

Patients were either treated once weekly with semaglutide 2.4 mg or a placebo for one year

You can read the full article at Tirzepatide (TZP), a new dual GIP/GLP-1 receptor agonist for treating type 2 diabetes (T2D), displayed superior outcomes in HbA1c reduction and patients achieving target levels compared to semaglutide and titrated insulin degludec across 40-weeks (SURPASS-2) and 52-weeks (SURPASS-3) studies